fbpx
  • Social Media
  • Login
  • Login
  • Become A Member
  • FAQ
  • Blog
  • Contact Us
  • Home
  • About Us
  • Find Professional
  • Find BUSINESS
    • Find Top BUSINESS
    • Business Hall of Fame
    • Business of the Year
  • Press Releases
  1. Health Services
  2. Retinal Specialist
  3. United States of America
  4. Pennsylvania
  5. Lancaster
  6. Dina Y. Gewaily MD, MS, FAAO

Dina Y. Gewaily MD, MS, FAAO

Retinal Specialist

Dina Y. Gewaily MD, MS, FAAO an Ophthalmologist with Lancaster Retina Specialist


  • bio
  • Career
  • Education
  • Industry
  • Press Releases
  • Career Accomplishments

Industry: Health Services

Press Releases By Dina Y. Gewaily MD, MS, FAAO

Nov 18, 2025

Global Directory of Who’s Who Honors Dr. Dina Y. Gewaily

Lancaster, PA – The Global Directory of Who’s Who proudly recognizes Dr. Dina Y. Gewaily, M.D., M.S., F.A.A.O., for her remarkable contributions to ophthalmology and her dedica


Read More

Career Accomplisments

National Siemens-Westinghouse Science and Technology Competition Semi-finalist, 2000

Invited Peer Reviewer 2013, RETINA: The Journal of Retinal and Vitreous Diseases

New York State Science Talent Search, High Honors, 2001

Invited Peer Reviewer 2014, Cochrane Eye and Vision Group (CEVG)

Intel Science Talent Search National Semi-finalist, 2001

Received Honors in every pre-clinical medical school course (Years I/II) at Brown Medical School

First female surgical retina fellow in the history of the University of Pennsylvania’s Scheie Eye Institute.

About: Dina Y. Gewaily MD, MS, FAAO an Ophthalmologist with Lancaster Retina Specialist

Industry: Health Services

Current Organization: Lancaster Retina Specialists

Specialty: Retinal Specialist

Website: https://centralparetina.com/

Career

Penn’s Scheie Eye Institute

Adjunct faculty

United States of America

Assistant Professor of Ophthalmology

United States of America

Published Works

(2014)

Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial: Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial

(2013)

Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial (CATT).”: Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial (CATT).”

(2012)

Gewaily D, Newcomb C, Levy-Clarke G, Nussenblatt R, Rosenbaum J, Suhler E, Thorne J, Foster CS, Jabs D, Kempen J. “Remission of intermediate uveitis: rate and predictive factors.” ARVO Confer: Gewaily D, Newcomb C, Levy-Clarke G, Nussenblatt R, Rosenbaum J, Suhler E, Thorne J, Foster CS, Jabs D, Kempen J. “Remission of intermediate uveitis: rate and predictive factors.” ARVO Confer

(2012)

Huang W, Wright A, Roman A, Cideciyan A, Manson F, Gewaily D, Schwartz S, Sadigh S, Limberis M, Bell P, Wilson J, Swaroop A, Jacobson S. “X-linked RP caused by RPGR mutations: natural history: Huang W, Wright A, Roman A, Cideciyan A, Manson F, Gewaily D, Schwartz S, Sadigh S, Limberis M, Bell P, Wilson J, Swaroop A, Jacobson S. “X-linked RP caused by RPGR mutations: natural history

(2009)

Peto T, Wolf-Schnurrbusch U, Powling A, Gewaily D, Marshall K. “Review of patients in Tower Hamlets with poor vision recorded in diabetic retinopathy screening.” 19 th European Association fo: Peto T, Wolf-Schnurrbusch U, Powling A, Gewaily D, Marshall K. “Review of patients in Tower Hamlets with poor vision recorded in diabetic retinopathy screening.” 19 th European Association fo

(2008)

Gewaily D, Greenberg PB, Anderson K. “Ophthalmology in late 19 th century America.” Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology. Atlanta,: Gewaily D, Greenberg PB, Anderson K. “Ophthalmology in late 19 th century America.” Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology. Atlanta,

(2008)

Gewaily D, Kane S, Al-Aswad LA. “Modification of Ahmed seton procedure in two pediatric cases.” Pediatric Grand Rounds presentation. Columbia University College of Physicians and Surgeons/Edw: Gewaily D, Kane S, Al-Aswad LA. “Modification of Ahmed seton procedure in two pediatric cases.” Pediatric Grand Rounds presentation. Columbia University College of Physicians and Surgeons/Edw

(2008)

Gewaily D, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion: a Cochrane systematic review.” 11 th Annual Residents Researc: Gewaily D, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion: a Cochrane systematic review.” 11th Annual Residents Research

(2008)

Gewaily D, Greenberg PB, Anderson K. “The great imitator: ocular manifestations of syphilis in 1897.” The New England Ophthalmological Society Meeting. Boston, MA. May 2008.: Gewaily D, Greenberg PB, Anderson K. “The great imitator: ocular manifestations of syphilis in 1897.” The New England Ophthalmological Society Meeting. Boston, MA. May 2008.

(2008)

Katsoulakis N, Gewaily D, Filippopoulos T, Rao S, Anderson K, Greenberg PB. “Accuracy of predicted refractive error in resident-performed cataract surgery using partial coherence interferomet: Katsoulakis N, Gewaily D, Filippopoulos T, Rao S, Anderson K, Greenberg PB. “Accuracy of predicted refractive error in resident-performed cataract surgery using partial coherence interferomet

(2007)

Gewaily D, Greenberg PB. “Intravitreal steroids for macular edema secondary to central retinal vein occlusion.” 15th Annual Lifespan/Brown Research Celebration. Providence, RI. November 2007.: Gewaily D, Greenberg PB. “Intravitreal steroids for macular edema secondary to central retinal vein occlusion.” 15th Annual Lifespan/Brown Research Celebration. Providence, RI. November 2007.

(2007)

Gewaily D, Haggag M. “Immunotherapy for allergic conjunctivitis: eyedrops or sublingual approach?” The Society of Microbiology and Immunology National conference. Cairo, Egypt. April 2007.: Gewaily D, Haggag M. “Immunotherapy for allergic conjunctivitis: eyedrops or sublingual approach?” The Society of Microbiology and Immunology National conference. Cairo, Egypt. April 2007.

(2007)

Gewaily D, Haggag M. “A naturally-based and cost-effective approach to the treatment of allergic conjunctivitis.” 4th Annual Unite for Sight conference. Stanford U. School of Medicine. Palo A: Gewaily D, Haggag M. “A naturally-based and cost-effective approach to the treatment of allergic conjunctivitis.” 4th Annual Unite for Sight conference. Stanford U. School of Medicine. Palo A

(2006)

Kim K, Tang X, Gewaily D, Li J, Wands J, Tong S. “Opposing effects of two naturally occurring mutations in Hepatitis B virus core protein on 2 nd strand DNA synthesis.” 12 th International Sy: Kim K, Tang X, Gewaily D, Li J, Wands J, Tong S. “Opposing effects of two naturally occurring mutations in Hepatitis B virus core protein on 2 nd strand DNA synthesis.” 12th International Sym

(2001)

Gewaily D, Seo Y, Samuilov V, Sokolov J, Rafailovich M. “Study of DNA morphology in a small droplet during evaporation.” Material Research Society National Symposium. Boston, MA. November 200: Gewaily D, Seo Y, Samuilov V, Sokolov J, Rafailovich M. “Study of DNA morphology in a small droplet during evaporation.” Material Research Society National Symposium. Boston, MA. November 200

(2017)

Russell S, Bennett J, Wellman JA, …[insert coauthors]…Gewaily D, ...Wright JF, High KA, Maguire AM. “Phase 3 efficacy and safety study of voretigene neparvovec (AAV2- hRPE65v2) in subjects wi: Russell S, Bennett J, Wellman JA, …[insert coauthors]…Gewaily D, ...Wright JF, High KA, Maguire AM. “Phase 3 efficacy and safety study of voretigene neparvovec (AAV2-hRPE65v2) in subjects wit

(2017)

Zhou H, Gewaily D, Ahn S, et al. “Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer.” Acce: Zhou H, Gewaily D, Ahn S, et al. “Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer.” Acce

(2016)

Zhou Q, Daniel E, Grunwald J, Maguire M, Gewaily D, Martin D, Ying G, on behalf of CATT Research Group. “Association between pseudodrusen and delayed patchy choroidal filling in the Compariso: Zhou Q, Daniel E, Grunwald J, Maguire M, Gewaily D, Martin D, Ying G, on behalf of CATT Research Group. “Association between pseudodrusen and delayed patchy choroidal filling in the Compariso

(2016)

Kempen J, Gewaily D, Newcomb C, et al. “Remission of intermediate uveitis: incidence and predictive factors.” Am J Ophthalmol.  2016 Jan 6. pii: S0002-9394(16)30002-2. doi: 10.1016/j.ajo.2015: Kempen J, Gewaily D, Newcomb C, et al. “Remission of intermediate uveitis: incidence and predictive factors.” Am J Ophthalmol.  2016 Jan 6. pii: S0002-9394(16)30002-2. doi: 10.1016/j.ajo.2015

(2015)

Gewaily D, Muthuswamy K, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.” Cochrane Database of Systematic Reviews 2015,: Gewaily D, Muthuswamy K, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.” Cochrane Database of Systematic Reviews 2015,

(2014)

Brodie FL , Charlson ES , Aleman TS , Salvo RT , Gewaily DY, Lau MK , Farren ND , Engelhard SB , Pistilli M , Brucker AJ . “Obstructive sleep apnea and central serous chorioretinopathy.” Reti: Brodie FL , Charlson ES , Aleman TS , Salvo RT , Gewaily DY, Lau MK , Farren ND , Engelhard SB , Pistilli M , Brucker AJ . “Obstructive sleep apnea and central serous chorioretinopathy.” Reti

(2014)

Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial: Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial

(2014)

Aleman T, Brodie F, Garvin C, Gewaily D, Ficicioglu C, Mills M, Forbes B, Maguire A, Davidson S. “Retinal structure in Cobalamin C Disease: mechanistic and therapeutic implications.” Ophthalm: Aleman T, Brodie F, Garvin C, Gewaily D, Ficicioglu C, Mills M, Forbes B, Maguire A, Davidson S. “Retinal structure in Cobalamin C Disease: mechanistic and therapeutic implications.” Ophthalm

(2012)

Huang W, Wright A, Roman A, Cideciyan A, Manson F, Gewaily D, Schwartz S, Sadigh S, Limberis M, Bell P, Wilson J, Swaroop A, Jacobson S. “X-linked RP caused by RPGR mutations: natural history: Huang W, Wright A, Roman A, Cideciyan A, Manson F, Gewaily D, Schwartz S, Sadigh S, Limberis M, Bell P, Wilson J, Swaroop A, Jacobson S. “X-linked RP caused by RPGR mutations: natural history

(2012)

Huang W, Roman A, Cideciyan A, Gewaily D,  Limberis A,  Bell P, Wilson J,  Wright A, Swaroop A,  Jacobson S. RPGR-associated retinal degeneration in human x-linked RP and a murine model. Inve: Huang W, Roman A, Cideciyan A, Gewaily D,  Limberis A,  Bell P, Wilson J,  Wright A, Swaroop A,  Jacobson S. RPGR-associated retinal degeneration in human x-linked RP and a murine model. Inve

(2009)

Gewaily D, Greenberg PB. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No: Gewaily D, Greenberg PB. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No

(2009)

Tsai A, Kawai S, Kwei K, Gewaily D, Hutter A, Tong D, Li J, Wands J, Tong S. “Chimeric constructs between two Hepatitis B virus genomes confirm transcriptional impact of core promoter mutatio: Tsai A, Kawai S, Kwei K, Gewaily D, Hutter A, Tong D, Li J, Wands J, Tong S. “Chimeric constructs between two Hepatitis B virus genomes confirm transcriptional impact of core promoter mutatio

(2008)

Gewaily D. Associate Author. USMLERx Flash Cards for First Aid for the USMLE Step 1, 2nd ed, 2008. USMLERx Step 1 Website. Available at: http://www.usmlerx.com .: Gewaily D. Associate Author. USMLERx Flash Cards for First Aid for the USMLE Step 1, 2nd ed, 2008. USMLERx Step 1 Website. Available at: http://www.usmlerx.com .

(2008)

Gewaily D, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion [protocol].” Cochrane Database of Systematic Reviews 2008, Iss: Gewaily D, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion [protocol].” Cochrane Database of Systematic Reviews 2008, Iss

(2006)

Kim K, Tang X, Gewaily D, Li J, Wands J, Tong S. “Opposing effects of two naturally occurring mutations in Hepatitis B virus core protein on 2 nd strand DNA synthesis.” 57 th Annual Meeting o: Kim K, Tang X, Gewaily D, Li J, Wands J, Tong S. “Opposing effects of two naturally occurring mutations in Hepatitis B virus core protein on 2 nd strand DNA synthesis.” 57th Annual Meeting of

(2006)

Gewaily D, Wands J, Tong S. “Hepatitis B virus isolated from liver cancer patients may possess increased replication capacity.” Brown University Sciences Library. 2006. 1- Size 1- N M2006 G49: Gewaily D, Wands J, Tong S. “Hepatitis B virus isolated from liver cancer patients may possess increased replication capacity.” Brown University Sciences Library. 2006. 1- Size 1- N M2006 G49

(2005)

Fang X, Li B, Gewaily D, Sokolov J, Rafailovich M. “Hildebrand solubility parameters measurement via sessile drops evaporation.” Appl. Phys. Lett. 2005; 87.: Fang X, Li B, Gewaily D, Sokolov J, Rafailovich M. “Hildebrand solubility parameters measurement via sessile drops evaporation.” Appl. Phys. Lett. 2005; 87.

(2015)

A Phase 2, double-masked, randomized, parallel-group study to investigate the safety, tolerability and efficacy of GSK933776 in adult patients with geographic atrophy (GA) secondary to age-re: A Phase 2, double-masked, randomized, parallel-group study to investigate the safety, tolerability and efficacy of GSK933776 in adult patients with geographic atrophy (GA) secondary to age-re

(2015)

Study of the choroid in patients with obstructive sleep apnea (OSA) – a prospective pilot feasibility study. IRB Protocol # 816732. “CSR/OSA.” Sub-investigator.: Study of the choroid in patients with obstructive sleep apnea (OSA) – a prospective pilot feasibility study. IRB Protocol # 816732. “CSR/OSA.” Sub-investigator.

(2015)

A randomized, double-masked, placebo-controlled study of the safety and efficacy of Gevokizumab and the treatment of subjects with non-infectious intermediate, posterior, or pan-uveitis curre: A randomized, double-masked, placebo-controlled study of the safety and efficacy of Gevokizumab and the treatment of subjects with non-infectious intermediate, posterior, or pan-uveitis curre

(2015)

Multi-center, randomized, single-masked phase 2 study of intravitreal sirolimus in the treatment of central geographic atrophy associated with age-related macular degeneration. IRB Protocol #: Multi-center, randomized, single-masked phase 2 study of intravitreal sirolimus in the treatment of central geographic atrophy associated with age-related macular degeneration. IRB Protocol #

(2015)

A randomized, placebo-controlled, parallel-group, double blind efficacy and safety trial of MK-8931 in subjects with mild to moderate Alzheimers disease. Protocol No. MK-8931- 017-03; also kn: A randomized, placebo-controlled, parallel-group, double blind efficacy and safety trial of MK-8931 in subjects with mild to moderate Alzheimers disease. Protocol No. MK-8931-017-03; also kno

(2015)

A randomized, placebo-controlled, parallel-group, double-blind efficacy and safety trial of MK-8931 with a long term double-blind extension in subjects with mild to moderate Alzheimers diseas: A randomized, placebo-controlled, parallel-group, double-blind efficacy and safety trial of MK-8931 with a long term double-blind extension in subjects with mild to moderate Alzheimers diseas

(2015)

A phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intra-vitreal administration of Fovista (Anti PDGF-B pegylated aptamer) administered in combinati: A phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intra-vitreal administration of Fovista (Anti PDGF-B pegylated aptamer) administered in combinati

(2015)

Study of comparative treatments for REtinal Vein Occlusion 2 (SCORE2): A multi-center, prospective, randomized, phase III, non-inferiority trial of eyes with macular edema secondary to centra: Study of comparative treatments for REtinal Vein Occlusion 2 (SCORE2): A multi-center, prospective, randomized, phase III, non-inferiority trial of eyes with macular edema secondary to centra

(2014)

Gewaily D. “Mystery Case.” Atlantic Coast Retina Club (ACRC) and Macula Society 2014 Meeting. Wills Eye Institute, Philadelphia, PA. January 2014.: Gewaily D. “Mystery Case.” Atlantic Coast Retina Club (ACRC) and Macula Society 2014 Meeting. Wills Eye Institute, Philadelphia, PA. January 2014.

(2014)

Grunwald JE, Gewaily D, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial: Grunwald JE, Gewaily D, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial

(2014)

Kempen J, Gewaily D, Artornsombudh P, SITE Cohort Study Research Group, et al. “Factors predictive of remission of new-onset anterior uveitis and of intermediate uveitis.” Podium presentation: Kempen J, Gewaily D, Artornsombudh P, SITE Cohort Study Research Group, et al. “Factors predictive of remission of new-onset anterior uveitis and of intermediate uveitis.” Podium presentati

(2014)

Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial: Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial

(2016)

Maguire A, [insert co-authors], Gewaily D, et al. Subretinal Injection Technique of Retinal Gene Therapy Applications. Macula Society. Miami Beach, FL. Feb. 24-27, 2016.: Maguire A, [insert co-authors], Gewaily D, et al. Subretinal Injection Technique of Retinal Gene Therapy Applications. Macula Society. Miami Beach, FL. Feb. 24-27, 2016.

Education Level: B.A.

Institute Name: Brown University

Location: United States of America

Education Level: M.S.

Institute Name: Brown University

Location: United States of America

Education Level: M.D.

Institute Name: Brown University

Location: United States of America

Education Level: Residency

Institute Name: Scheie Eye Institute

Location: United States of America

Vitreo-retinal Diseases and Surgery

Education Level: Fellowship

Institute Name: Scheie Eye Institute

Location: Pennsylvania, United States of America

Contact Info

  • Call Us: (717) 399-8790
  • Contact
  • https://centralparetina.com/
  • 2150 Harrisburg Pike , Pennsylvania, Lancaster, 17601
Show Map Location

Quick Contact

© Eastern Seaboard Publishing, LLC
  • Disclaimer
  • Contact Us
  • Privacy Policy